Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective Study.
Bolzacchini E, Pinotti G, Bertù L, Verusio C, Galli L, Mumoli N, Barbara C, Danova M, Bregni M, Artale S, Rossini C, Nigro O, Antonuzzo A, Derosa L, Torchio M, Barzaghi S, Ricci I, Suter M, Ballerio A, Vallini I, Dentali F. Bolzacchini E, et al. Among authors: galli l. Clin Genitourin Cancer. 2020 Apr;18(2):e145-e156. doi: 10.1016/j.clgc.2019.10.003. Epub 2019 Dec 5. Clin Genitourin Cancer. 2020. PMID: 31889670
A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.
Ricci S, Antonuzzo A, Galli L, Tibaldi C, Bertuccelli M, Lopes Pegna A, Petruzzelli S, Bonifazi V, Orlandini C, Franco Conte P. Ricci S, et al. Among authors: galli l. Cancer. 2000 Oct 15;89(8):1714-9. doi: 10.1002/1097-0142(20001015)89:8<1714::aid-cncr10>3.0.co;2-7. Cancer. 2000. PMID: 11042565 Clinical Trial.
Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancer.
Galli L, Fontana A, Galli C, Landi L, Fontana E, Antonuzzo A, Andreuccetti M, Aitini E, Barbieri R, Di Marsico R, Falcone A. Galli L, et al. Among authors: galli c. Br J Cancer. 2007 Dec 17;97(12):1613-7. doi: 10.1038/sj.bjc.6604090. Epub 2007 Nov 20. Br J Cancer. 2007. PMID: 18026196 Free PMC article. Clinical Trial.
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer.
Fontana A, Galli L, Fioravanti A, Orlandi P, Galli C, Landi L, Bursi S, Allegrini G, Fontana E, Di Marsico R, Antonuzzo A, D'Arcangelo M, Danesi R, Del Tacca M, Falcone A, Bocci G. Fontana A, et al. Among authors: galli l, galli c. Clin Cancer Res. 2009 Aug 1;15(15):4954-62. doi: 10.1158/1078-0432.CCR-08-3317. Epub 2009 Jul 21. Clin Cancer Res. 2009. PMID: 19622584 Clinical Trial.
The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
Ageno W, Cosmi B, Ghirarduzzi A, Santoro R, Bucherini E, Poli D, Prisco D, Alatri A, Pengo V, Galli L, Dentali F, Palareti G. Ageno W, et al. Among authors: galli l. Am J Hematol. 2012 Jul;87(7):713-5. doi: 10.1002/ajh.23198. Epub 2012 Apr 10. Am J Hematol. 2012. PMID: 22488507 Free article. Clinical Trial.
1,153 results